Borosil Scientific Ltd

Borosil Scientific Ltd

₹ 152 0.73%
02 Jun 3:12 p.m.
About

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Key Points

Borosil Group[1]
The company is a part of Borosil group which is into glassware and laboratory products,
scientific & industrial glassware, consumer & kitchenware products, and solar glass products. Group comprises of:
1. Borosil Renewables Ltd
2. Borosil Ltd
3. Borosil Scientific Ltd

  • Market Cap 1,354 Cr.
  • Current Price 152
  • High / Low 191 / 96.6
  • Stock P/E 33.7
  • Book Value 49.6
  • Dividend Yield 0.00 %
  • ROCE 12.1 %
  • ROE 9.52 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 3.08 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 7.61% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
88 92 100 116 104 103 101 129 96 107 121 143
82 82 88 97 94 87 91 113 91 99 104 111
Operating Profit 6 9 12 18 10 16 10 17 5 8 17 32
OPM % 7% 10% 12% 16% 9% 15% 10% 13% 5% 8% 14% 22%
1 1 1 1 2 2 2 3 -4 2 0 2
Interest 1 1 1 1 0 0 0 0 0 0 0 0
Depreciation 4 4 4 4 5 5 5 5 5 5 5 5
Profit before tax 2 6 8 15 7 12 7 14 -4 5 13 29
Tax % -36% 20% 30% 35% 28% 29% 38% 39% 3% 44% 31% 7%
3 5 6 9 5 9 4 9 -4 3 9 27
EPS in Rs 0.65 1.05 0.57 0.99 0.48 0.97 -0.47 0.32 0.98 3.06
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
392 434 467
345 381 405
Operating Profit 47 53 62
OPM % 12% 12% 13%
4 8 1
Interest 3 2 1
Depreciation 16 18 19
Profit before tax 32 40 43
Tax % 26% 34% 19%
23 27 35
EPS in Rs 2.65 3.01 3.89
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 50%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 5%
Return on Equity
10 Years: %
5 Years: %
3 Years: 8%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
Equity Capital 9 9 9
Reserves 367 395 432
18 14 9
95 86 99
Total Liabilities 488 504 549
192 187 189
CWIP 1 1 9
Investments 0 105 122
295 210 229
Total Assets 488 504 549

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
30 120 43
-2 -115 -37
-16 -3 -6
Net Cash Flow 12 1 -0
Free Cash Flow 17 106 16
CFO/OP 97% 249% 93%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
Debtor Days 57 59 59
Inventory Days 244 218 226
Days Payable 102 79 93
Cash Conversion Cycle 200 199 192
Working Capital Days 165 86 179
ROCE % 10% 12%

Insights

In beta
Mar 2024 Mar 2025
Distribution Network (Channel Partners)
Number

Log in to view insights

Please log in to see hidden values.

Login
Export Presence
Countries
Market Share in Laboratory Glassware (India)
%
Product Range (Total SKUs)
Number
Production Capacity - Glass Ampoules
Million Units per annum ・Standalone data
Production Capacity - Laboratory Glassware
Units per day ・Standalone data
Production Capacity - Tubular Glass Vials
Million Units per annum ・Standalone data
Serviceable Addressable Market - Laboratory Glassware
INR Crores

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
67.92% 67.86% 67.84% 67.81% 67.80% 67.80% 67.80% 68.08%
0.38% 0.37% 0.27% 0.24% 0.20% 0.07% 0.07% 0.09%
0.15% 0.01% 0.02% 0.02% 0.05% 0.10% 0.19% 0.26%
31.54% 31.74% 31.88% 31.91% 31.93% 32.03% 31.93% 31.57%
No. of Shareholders 62,35461,20160,37358,89458,17857,58656,29755,319

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents